Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether Bimosiamose Cream is safe and effective in the treatment of plaque type psoriasis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Revotar Biopharmaceuticals AG

Criteria

Inclusion Criteria:

• Clinical diagnosis of plaque type psoriasis PASI score of 5-15

• At least 18 years of age

• Written informed consent

Exclusion Criteria:

• Active skin infection

• More than 20% Body Surface Area (BSA) affected by psoriasis

• Use of certain anti-psoriasis medication or treatments